Results 41 to 50 of about 1,602 (208)

Plasmonic Nanotags for On‐Dose Authentication of Medical Tablets

open access: yesAdvanced Materials Interfaces, Volume 10, Issue 20, July 17, 2023., 2023
Self‐assembled gold nanoparticles with Raman‐active reporting molecules are applied to stealth Nanotags to develop a novel anticounterfeiting technology. Plasmonic Nanotags enable the on‐dose authentication of medical tablets. Rapid authentication of tablets stocked over 8 years is sufficiently carried out.
Takao Fukuoka   +4 more
wiley   +1 more source

Applications of ambient ionization mass spectrometry in 2022: An annual review

open access: yesAnalytical Science Advances, Volume 4, Issue 5-6, Page 133-153, July 2023., 2023
Abstract The development of ambient ionization mass spectrometry (AIMS) has transformed analytical science, providing the means of performing rapid analysis of samples in their native state, both in and out of the laboratory. The capacity to eliminate sample preparation and pre‐MS separation techniques, leading to true real‐time analysis, has led to ...
Stephanie Rankin‐Turner   +2 more
wiley   +1 more source

Real‐world burden and treatment of chronic rhinosinusitis in Japan: A retrospective claims database analysis

open access: yesLaryngoscope Investigative Otolaryngology, Volume 8, Issue 2, Page 346-356, April 2023., 2023
Abstract Objectives Chronic rhinosinusitis (CRS) is a heterogeneous disease, which can be subdivided into CRS with (CRSwNP) or without (CRSsNP) nasal polyps. An intractable form of CRSwNP that is associated with an eosinophil‐dominant inflammatory cell infiltration (eosinophilic CRS) has become more prevalent in Japan.
Mamoru Yoshikawa   +4 more
wiley   +1 more source

Clinical features, therapeutic outcomes, and recovery period of long COVID

open access: yesJournal of Medical Virology, Volume 95, Issue 1, January 2023., 2023
Abstract To characterize the clinical features of long COVID, 286 patients who received care in our outpatient clinic for long COVID from May to December 2021 were surveyed. The recovery periods of each symptom and the key factors contributing to early recovery were statistically analysed. The median age of the patients was 35.8 years, with 137 men and
Kazuki Takakura   +3 more
wiley   +1 more source

Tiao‐Bu‐Fei‐Shen Formula Improves Glucocorticoid Resistance of Chronic Obstructive Pulmonary Disease via Downregulating the PI3K‐Akt Signaling Pathway and Promoting GRα Expression

open access: yesEvidence-Based Complementary and Alternative Medicine, Volume 2023, Issue 1, 2023., 2023
Objective. To predict and determine the mechanism through which Tiao‐Bu‐Fei‐Shen (TBFS) formula improves glucocorticoid resistance in chronic obstructive pulmonary disease (COPD), using network pharmacology, molecular docking technology, and in vitro studies. Methods.
Pengcheng Zhou   +6 more
wiley   +1 more source

Mucus Hypersecretion in Chronic Obstructive Pulmonary Disease and Its Treatment

open access: yesMediators of Inflammation, Volume 2023, Issue 1, 2023., 2023
Most patients diagnosed with chronic obstructive pulmonary disease (COPD) present with hallmark features of airway mucus hypersecretion, including cough and expectoration. Airway mucus function as a native immune system of the lung that severs to trap particulate matter and pathogens and allows them to clear from the lung via cough and ciliary ...
Binay Kumar Shah   +5 more
wiley   +1 more source

Mucolytics/antioxidants: When Are They Useful?

open access: yesBarcelona Respiratory Network Reviews, 2023
Several national and international guidelines acknowledge the potential value of mucolytics/ antioxidants N-acetylcysteine (NAC), carbocysteine and erdosteine, which are thiol- based drugs, in the treatment of stable chronic obstructive pulmonary disease
Mario Cazzola   +3 more
doaj   +1 more source

The role of HMGB1/RAGE/TLR4 signaling pathways in cigarette smoke‐induced inflammation in chronic obstructive pulmonary disease

open access: yesImmunity, Inflammation and Disease, Volume 10, Issue 11, November 2022., 2022
High mobility group box 1 (HMGB1) is a typical damage‐associated molecular pattern protein, which mainly exerts its activity by binding to the receptor for advanced glycation end products (RAGE) and toll‐like receptor 4 (TLR4) and further participates in the process of airway inflammation. We discussed the role of HMGB1, RAGE, and TLR4 in the cigarette
Ling Lin   +4 more
wiley   +1 more source

Medicinal Foods, YT and RH Combination, Suppress Cigarette Smoke‐Induced Inflammation and Oxidative Stress by Inhibiting NF‐κB/ERK Signaling Pathways

open access: yesEvidence-Based Complementary and Alternative Medicine, Volume 2022, Issue 1, 2022., 2022
Background. Cigarette smoke is a risk factor for Chronic Obstructive Pulmonary Disease (COPD). Given the lack of COPD curative treatment, dietary management for COPD patients has become important. This study investigated whether the medicinal foods (YT and RH) could suppress cigarette smoke exposure‐induced inflammation and oxidative stress.
Yuanyuan Li   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy